You are here

Heart Failure

 

A clinical risk score helped predict the risk of ischemic stroke, thromboembolism and death in patients with heart failure, according to an analysis of three nationwide registries in Denmark. However, the researchers noted the predictive accuracy was modest.

 

Recent Headlines

Clinical risk score helps predict stroke and death in heart failure patients

A clinical risk score helped predict the risk of ischemic stroke, thromboembolism and death in patients with heart failure, according to an analysis of three nationwide registries in Denmark. However, the researchers noted the predictive accuracy was modest.

Nearly 90% of patients with heart failure are not referred to cardiac rehabilitation

Only 10 percent of patients with heart failure were referred to cardiac rehabilitation after hospital discharge between 2005 and 2014, according to a database analysis. Although the referral rates were higher in recent years, the researchers noted that they expected more people to be told to attend cardiac rehabilitation sessions.

Symptoms persist in patients hospitalized for heart failure

A large percentage of patients hospitalized for heart failure at Yale-New Haven hospital had symptoms such as anxiety and pain that are typically not associated with the condition, according to a prospective study. The researchers also found that patients often did not have improvements in symptom severity after getting discharged.

Moderate levels of physical activity may reduce heart failure risk in men

After a mean follow-up of 13 years, Swedish men who had moderate levels of physical activity had a lower risk of heart failure compared with those who had high or low activity levels, according to a population-based cohort study.

FDA warns of serious adverse events with LVADs

The FDA warned of serious adverse events associated with certain left ventricular assist devices (LVADs), which are implanted in patients with advanced heart failure.

Social media sites growing in popularity for LVAD patients and caregivers

Since former Vice President Dick Cheney had a left ventricular assist device (LVAD) implanted in 2012, general interest in the devices have increased and social media sites have included more information on them.

Investigational cardiac implantable device shows no improvement over placebo

Bellerophon Therapeutics announced on July 27 that top-line results from a clinical trial found its investigational cardiac implantable device did not improve outcomes compared with placebo.

St. Jude Medical to acquire Thoratec for $3.4 billion in cash

St. Jude Medical agreed to acquire Thoratec for approximately $3.4 billion to expand its heart failure business. When the deal is finalized, Thoratec shareholders will receive $63.50 per share in cash, a 10 percent increase over Thoratec’s closing price the day before the announcement.

Intervention improves survival following out-of-hospital cardiac arrest

A statewide intervention in North Carolina improved survival and led to an increased number of people receiving bystander and first-responder-initiated CPR and defibrillation following out-of-hospital cardiac arrest. The efforts were enacted after the American Heart Association issued a policy statement in 2010 asking for regional centers to care for patients who suffer from cardiac arrest.

Personalized site feedback does not improve upon 'Get With The Guidelines' results

An intervention designed to improve outcomes in heart failure patients by offering sites feedback on adherence to guidelines did not lead to better quality of care in hospitals, according to a cluster-randomized trial.

Pages